Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 4 1Phase 1 1

Status

Completed 34Terminated 18Recruiting 14Active not recruiting 6Unknown 5Not yet recruiting 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1

Conditions

Breast Neoplasms 1282Carcinoma, Non-Small-Cell Lung 786Neoplasms 774Colorectal Neoplasms 758Stomach Neoplasms 586Carcinoma, Hepatocellular 580Prostatic Neoplasms 508Lung Neoplasms 461Pancreatic Neoplasms 418Rectal Neoplasms 332Recurrence 314Neoplasm Metastasis 309Leukemia, Myeloid, Acute 292Multiple Myeloma 280Colonic Neoplasms 280Lymphoma 275Uterine Cervical Neoplasms 272Esophageal Neoplasms 269Ovarian Neoplasms 262Head and Neck Neoplasms 245Melanoma 242Precursor Cell Lymphoblastic Leukemia-Lymphoma 210Brain Neoplasms 195Lymphoma, Large B-Cell, Diffuse 186Nasopharyngeal Carcinoma 181Leukemia 173Lymphoma, Non-Hodgkin 171Liver Neoplasms 163Glioblastoma 160Polycystic Ovary Syndrome 155

Interventions

tanezumab 1Sirolimus 1Panobinostat 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Interventional × Hereditary Sensory and Autonomic Neuropathies × Clear all
NCT05103358 2024-06-03

Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)

Aadi Bioscience, Inc.

Phase 2 Unknown
120 enrolled

Tuberous Sclerosis 1, Tuberous Sclerosis 2, Neoplasm Metastasis, Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT04163419 2024-03-13

Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis

Massachusetts General Hospital

Phase 2 Unknown
9 enrolled

Schwannomatosis, Neurilemmoma, Hereditary Sensory and Autonomic Neuropathies, Pain

NCT05750693 2023-03-02

PIK3CA in HER2+ BC and pCR Trial

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Unknown
58 enrolled

Pathologic Complete Response, Hereditary Sensory and Autonomic Neuropathies

NCT03781050 2019-01-23

Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome

Peking Union Medical College Hospital

Phase 4 Unknown
10 enrolled

Hereditary Sensory and Autonomic Neuropathies, Peutz-Jeghers Syndrome

NCT01341834 2018-04-24

Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors

National Cancer Centre, Singapore

Phase 1 Unknown
49 enrolled
Head & NeckLymphoid

Nasopharyngeal Carcinoma, Lymphoma, Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡